Corpus Intelligence IC Memo — TANNER MEDICAL CENTER ALABAMA INC. 2026-04-26 15:53 UTC
IC Memo — TANNER MEDICAL CENTER ALABAMA INC.
Investment Committee Memorandum | AL | 15 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TANNER MEDICAL CENTER ALABAMA INC.

CCN 011306 | nan, AL | 15 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TANNER MEDICAL CENTER ALABAMA INC. is a 15-bed rural/critical access in nan, AL with $15.0M in net patient revenue and a -12.0% operating margin. The hospital serves a payer mix of 41.4% Medicare, 5.6% Medicaid, and 53.0% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.0% to -4.6% (+736bps).

Net Revenue HCRIS$15.0M
Current EBITDA COMPUTED$-1.8M
Operating Margin COMPUTED-12.0%
Occupancy HCRIS26.7%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS33.5%
Distress Probability ML54.9%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
17
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -12.0% places it below the state median. Among 17 size-comparable peers (8-30 beds), the median margin is -24.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-30), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TANNER MEDICAL CENTER ALABAMA (Target)AL15$15.0M-12.0%
ST. VINCENTS CHILTONAL26$29.1M9.2%
ST. VINCENTS BLOUNTAL25$25.2M-33.1%
NORTHWEST MEDICAL CENTERAL28$23.8M-12.1%
BIBB MEDICAL CENTERAL25$19.8M-20.1%
CHOCTAW GENERAL HOSPITALAL25$17.7M-2.8%
MEDICAL CENTER BARBOURAL30$17.6M-34.1%
WASHINGTON COUNTY HOSPITALAL15$16.2M-6.6%
BULLOCK COUNTY HOSPITALAL29$13.9M-24.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$316K+210bp18mo
Cost to Collect4.5%2.5%$301K+200bp12mo
Denial Rate Reduction12.0%6.5%$298K+198bp12mo
A/R Days Reduction5200.0%3800.0%$183K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$316K
Cost to Collect
$301K
Denial Rate Reduction
$298K
A/R Days Reduction
$183K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-1.8M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$-693K
Current Margin-12.0%
Pro Forma Margin-4.6%
WC Released (1x)$577K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.8M$-808K0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.8M$-1.8M0.00x-100.0%
Bull Case9.0x11.0x$-2.5M$964K0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.5M$316K0.00x-100.0%
Bear Case11.0x10.0x$-3.0M$-5.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.0M$-7.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 26.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 8-30 beds
  • Same-state prioritization (n=18)
  • Comp margins: P25=-50.0% / P50=-24.8% / P75=-10.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.